The organization’s legacy CMS and architecture limited innovation and created an outdated user experience. The platform was incompatible with modern technologies and slowed the creation of new, high-value content.
Content and digital assets were managed primarily by IT teams, increasing dependency and extending publishing cycles. Multiple information sources and a prolonged time-to-market further complicated corporate communications.
TBSCG delivered a Magnolia CMS and API layer solution designed for flexibility, scalability, and long-term growth. The solution established a future-ready, composable architecture that reduced operational complexity, empowered content teams with greater autonomy, and provided a resilient foundation for sustained digital innovation. Key elements included:
"Our new Magnolia platform provides the reliability and flexibility needed to support corporate communications and future innovation."
Corporate Communications Lead, Swiss Biopharmaceutical Company
The corporate communications team now relies on a modern, supported Magnolia CMS platform.
A seamless and intuitive user journey built on clearly defined components improves engagement and usability.
The scalable, future-proof architecture accommodates increasing traffic and evolving technology requirements.
Business users can create, edit, review, and manage content independently, drastically reducing time-to-market.
This biopharmaceutical company specializes in the discovery, development, and commercialization of innovative small-molecule medicines.
Focused on advancing new therapeutic options, the organization required a modern digital platform capable of supporting global corporate communications, regulatory transparency, and investor engagement.